MG
ATRC icon

Mather Group’s AtriCure ATRC Stock Holding History

Mather Group’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420 Sell
15
-40
-73% -$1.13K ﹤0.01% 1838
2026
Q1 		$1.57K Buy
+55
New +$1.88K ﹤0.01% 1725
2025
Q4 		– Sell
-195
Closed -$6.87K – 713
2025
Q3 		$6.87K Buy
+195
New +$6.72K ﹤0.01% 1332
2025
Q2 		– Sell
-183
Closed -$5.9K – 682
2025
Q1 		$5.9K Buy
183
+120
+190% +$4.46K ﹤0.01% 1372
2024
Q4 		$1.93K Sell
63
-7
-10% -$225 ﹤0.01% 1544
2024
Q3 		$1.96K Sell
70
-660
-90% -$16.3K ﹤0.01% 1490
2024
Q2 		$22.2K Buy
730
+565
+342% +$13K ﹤0.01% 1243
2024
Q1 		$5.89K Buy
+165
New +$5.53K ﹤0.01% 1324
2023
Q3 		– Sell
-3,212
Closed -$159K – 537
2023
Q2 		$159K Buy
+3,212
New +$148K ﹤0.01% 556

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Mather Group's ATRC Position: Q2 2026 in Review

Mather Group reduced its AtriCure (ATRC) stake by 73% in Q2 2026, selling an estimated $1.13K and leaving 15 shares worth $420. The position accounts for ﹤0.01% of the portfolio, ranked #1838.

Mather Group first reported a position in ATRC in Q2 2023 and has held it in 9 quarters since. The position peaked at $159K in Q2 2023. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Mather Group held 15 shares of AtriCure worth $420 as of Q2 2026.
  • Mather Group sold 40 AtriCure shares in Q2 2026, an estimated $1.13K.
  • AtriCure made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1838 holding.
  • Mather Group first reported a position in AtriCure in Q2 2023 and has held it in 9 quarters since.
  • Mather Group's AtriCure position peaked at $159K in Q2 2023.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.